ofloxacin has been researched along with Sinusitis, Maxillary in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (90.91) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Das, S; Mondal, S | 1 |
| Kern, WV; Marre, R; Perner, S; Rentschler, J; Sing, A; Wellinghausen, N | 1 |
| Greene, BL | 1 |
| Gerasimov, KV; Kriukov, AI; Sedinkin, AA | 1 |
| Bunnag, C; Dhiraputra, C; Fooanant, S; Jareoncharsri, P; Srifuengfung, S; Tunsuriyawong, P; Voraprayoon, S | 1 |
| Breen, JD; Emparanza, P; Lesinskas, E; Murray, JJ; Tawadrous, M | 1 |
| Marple, BF | 1 |
| Ambrose, PG; Anon, JB; Jones, RN; Kahn, JB; Paglia, M; Xiang, J | 1 |
| Ambrose, PG; Anon, JB; Bhavnani, SM; Drusano, GL; Jones, RN; Kahn, J; Okusanya, OO; Paglia, MR | 1 |
| Gwaltney, JM | 1 |
| Budanov, SV; Smirnova, LB; Vasil'ev, AN | 1 |
1 review(s) available for ofloxacin and Sinusitis, Maxillary
| Article | Year |
|---|---|
[The first 'respiration' fluoroquinolone--levofloxacin (Tavanic) in therapy of bacterial infections. Pharmacodynamics principles in optimization of administration regimens].
Topics: Acute Disease; Animals; Anti-Infective Agents; Bronchitis; Chronic Disease; Community-Acquired Infections; Humans; Levofloxacin; Maxillary Sinusitis; Ofloxacin; Pneumonia, Bacterial; Respiratory Tract Infections; Urinary Tract Infections | 2001 |
5 trial(s) available for ofloxacin and Sinusitis, Maxillary
| Article | Year |
|---|---|
[Efficacy of the drug tavanik (levofloxacin) in acute and maxillary sinusitis].
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Drug Administration Schedule; Female; Humans; Levofloxacin; Male; Maxillary Sinusitis; Middle Aged; Ofloxacin | 2003 |
An open label, randomized comparative study of levofloxacin and amoxicillin/clavulanic acid in the treatment of purulent sinusitis in adult Thai patients.
Topics: Acute Disease; Adolescent; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Drug Therapy, Combination; Female; Humans; Levofloxacin; Male; Maxillary Sinusitis; Middle Aged; Ofloxacin; Suppuration | 2004 |
Efficacy and safety of a novel, single-dose azithromycin microsphere formulation versus 10 days of levofloxacin for the treatment of acute bacterial sinusitis in adults.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Azithromycin; Bacterial Infections; Chemistry, Pharmaceutical; Confidence Intervals; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; International Cooperation; Levofloxacin; Male; Maxillary Sinusitis; Microspheres; Middle Aged; Ofloxacin; Probability; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2005 |
Serial sinus aspirate samples during high-dose, short-course levofloxacin treatment of acute maxillary sinusitis.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Catheters, Indwelling; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Levofloxacin; Male; Maxillary Sinusitis; Microbial Sensitivity Tests; Middle Aged; Moraxella catarrhalis; Moraxellaceae Infections; Ofloxacin; Pneumococcal Infections; Streptococcus pneumoniae; Time Factors; Treatment Outcome | 2007 |
Use of pharmacodynamic endpoints for the evaluation of levofloxacin for the treatment of acute maxillary sinusitis.
Topics: Adult; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Female; Humans; Levofloxacin; Male; Maxillary Sinus; Maxillary Sinusitis; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Ofloxacin; Peroxidase; Pilot Projects; Plasma; Radiography; Time Factors; United States | 2008 |
5 other study(ies) available for ofloxacin and Sinusitis, Maxillary
| Article | Year |
|---|---|
Oral levofloxacin-induced optic neuritis progressing in loss of vision.
Topics: Administration, Oral; Anti-Bacterial Agents; Ethmoid Sinusitis; Humans; Levofloxacin; Male; Maxillary Sinusitis; Middle Aged; Ofloxacin; Optic Neuritis; Vision Disorders | 2012 |
A fatal case of necrotizing sinusitis due to toxigenic Corynebacterium ulcerans.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Corynebacterium; Corynebacterium Infections; Diphtheria Toxin; Fatal Outcome; Humans; Imipenem; Male; Maxillary Sinusitis; Necrosis; Ofloxacin; Peptide Fragments | 2002 |
Physical therapist management of fluoroquinolone-induced Achilles tendinopathy.
Topics: Achilles Tendon; Adult; Anti-Infective Agents; Humans; Levofloxacin; Male; Maxillary Sinusitis; Ofloxacin; Orthotic Devices; Physical Therapy Modalities; Rupture; Treatment Outcome | 2002 |
Editorial commentary: dilemma in trial design: do current study designs adequately evaluate effectiveness antibiotic in ABRS?
Topics: Acute Disease; Azithromycin; Bacterial Infections; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Maxillary Sinusitis; Microspheres; Ofloxacin; Randomized Controlled Trials as Topic; Rhinitis; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2005 |
Commentary on "Use of pharmacodynamic endpoints for the evaluation of levofloxacin for the treatment of acute maxillary sinusitis" by Ambrose et al.
Topics: Anti-Bacterial Agents; Bacterial Infections; Humans; Levofloxacin; Maxillary Sinusitis; Ofloxacin | 2008 |